Skip to main content

Table 1 Characteristic and quality of retrieved studies

From: Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis

Reference

Year

Country, year

Patient Number (after PSM)

Maximum follow up (years)

PSM

Design

Quality score

TMT

RC

Bekelman [23]

2013

SEER, 1995–2005

417

1426

9

None

R

15

Kim [22]

2017

Korea, 2007–2014

32 (29)

308 (50)

5

1,2,5,6,10

R

15

Kulkarni [21]

2017

Single-center, 2008–2013

(56)

(56)

6

1,2,5,6,10

R

16

Williams [20]

2018

SEER, 2002–2011

752 (687)

2448 (687)

10

1,2,4,9,5,7,10

R

19

Zhong [19]

2019

NCDB, 2004–2013

1178 (1002)

7276 (1002)

10

1,5,6,7,8

R

18

Kumar [13]

2021

US Veterans, 2000–2017

163

1472

5

None

R

17

Qiu [18]

2022

CaPRICE, 2005–2014

(891)

(891)

15

1,2,3,4,5,6

R

18

  1. 1 = age, 2 = gender, 3 = year at treatment, 4 = education achievement, 5 = clinical T stage, and 6 = Charlson Comorbidity Index, 7 = disease site, 8 = facility type, 9 = marital status, 10 = grade
  2. R retrospective, PSM Propensity scoring matching